hen a share has cratered for reasons other than pure fundamentals, it can enjoy a major rebound. German multinational pharma and biotech firm could be a classic case in point. Founded 160 years ago as a manufacturer and seller of synthetic dyes, Bayer is now one of the largest drugmakers in the world.
Shares in Bayer should bounce back
Jan 20, 2023
2 minutes
You’re reading a preview, subscribe to read more.
Start your free 30 days